LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LOX-1 is a poor prognostic indicator and induces epithelial-mesenchymal transition and metastasis in pancreatic cancer patients
Authors
Keywords
Pancreatic cancer, LOX-1, Prognostic factor, Metastasis, Epithelial-mesenchymal transition
Journal
CELLULAR ONCOLOGY
Volume 41, Issue 1, Pages 73-84
Publisher
Springer Nature
Online
2017-11-22
DOI
10.1007/s13402-017-0360-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/ TGF-β1/KLF6 signaling pathway in diabetic pulmonary fibrosis
- (2017) Xiao-Zhou Zou et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells
- (2017) Maria Saveria Gilardini Montani et al. CELLULAR ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits
- (2016) Lan Wang et al. GASTROENTEROLOGY
- Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
- (2016) V. Taucher et al. CELLULAR ONCOLOGY
- Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development
- (2016) Matteo Giulietti et al. CELLULAR ONCOLOGY
- The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer
- (2016) Michela Murdocca et al. Oncotarget
- Role of EMT in Metastasis and Therapy Resistance
- (2016) Bethany Smith et al. Journal of Clinical Medicine
- Cancer as a Proinflammatory Environment: Metastasis and Cachexia
- (2015) Nelson Inácio Pinto et al. MEDIATORS OF INFLAMMATION
- Oxidized low-density lipoprotein is associated with advanced-stage prostate cancer
- (2015) Fangning Wan et al. TUMOR BIOLOGY
- Pancreatic Adenocarcinoma
- (2015) David P. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential prooxidative effects of the green tea polyphenol, (-)-epigallocatechin-3-gallate, in normal and oral cancer cells are related to differences in sirtuin 3 signaling
- (2014) Ling Tao et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
- (2013) Y. Zhang et al. CANCER RESEARCH
- Screening for Pancreatic Cancer
- (2012) Katherine E. Poruk et al. ANNALS OF SURGERY
- The Discovery of LOX-1, its Ligands and Clinical Significance
- (2011) Ryo Yoshimoto et al. CARDIOVASCULAR DRUGS AND THERAPY
- Oxidized LDL, LOX-1 and Atherosclerosis
- (2011) Sona Mitra et al. CARDIOVASCULAR DRUGS AND THERAPY
- CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme
- (2011) Xue Qiang Zhao et al. JOURNAL OF LIPID RESEARCH
- A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases
- (2010) Heather A. Hirsch et al. CANCER CELL
- K-Ras Promotes Angiogenesis Mediated by Immortalized Human Pancreatic Epithelial Cells through Mitogen-Activated Protein Kinase Signaling Pathways
- (2009) Y. Matsuo et al. MOLECULAR CANCER RESEARCH
- Specific Expression of Endoglin (CD105) in Endothelial Cells of Intratumoral Blood and Lymphatic Vessels in Pancreatic Cancer
- (2008) Hideyuki Yoshitomi et al. PANCREAS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now